These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34078130)
21. Association of Controlling Nutritional Status Score With Adverse Outcomes in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis. Huang L; He R; Sun X; Lv J; Chen S Angiology; 2023 Feb; 74(2):149-158. PubMed ID: 35491724 [TBL] [Abstract][Full Text] [Related]
22. Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis. Yang Y; Zhang X; Jin Z; Zhao Q J Thromb Thrombolysis; 2021 Nov; 52(4):1084-1093. PubMed ID: 33966143 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus. Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010 [TBL] [Abstract][Full Text] [Related]
24. Association of D-dimer with long-term prognosis in type 2 diabetes mellitus patients with acute coronary syndrome. Zhou BY; Zhang Q; Hu YC; Wang L; Zhang JX; Cong HL; Wang L Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1955-1962. PubMed ID: 35752544 [TBL] [Abstract][Full Text] [Related]
25. Predictive value of circulating cystatin C level in patients with acute coronary syndrome: a meta-analysis. Jin S; Xu J; Shen G; Gu P Scand J Clin Lab Invest; 2021 Feb; 81(1):1-7. PubMed ID: 33207943 [TBL] [Abstract][Full Text] [Related]
26. Copeptin and the prognosis of patients with coronary artery disease: a meta-analysis. Shi Z; Qian C Ir J Med Sci; 2023 Oct; 192(5):2129-2141. PubMed ID: 36719516 [TBL] [Abstract][Full Text] [Related]
27. Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies. Ding K; Shi Z; Qian C; Yang X Front Cardiovasc Med; 2021; 8():726289. PubMed ID: 35083296 [No Abstract] [Full Text] [Related]
28. Association of N-terminal pro-brain natriuretic peptide level with adverse outcomes in patients with acute myocardial infarction: A meta-analysis. Shen S; Ye J; Wu X; Li X Heart Lung; 2021; 50(6):863-869. PubMed ID: 34340134 [TBL] [Abstract][Full Text] [Related]
29. Depression predicts the risk of adverse events after percutaneous coronary intervention: A meta-analysis. Song X; Song J; Shao M; Gao X; Ji F; Tian H; Xu Y; Zhuo C J Affect Disord; 2020 Apr; 266():158-164. PubMed ID: 32056871 [TBL] [Abstract][Full Text] [Related]
30. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis. Zhao Y; Guo M; Shi G Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793983 [TBL] [Abstract][Full Text] [Related]
31. The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis. Zhang S; Ding Y; Feng F; Gao Y Front Cardiovasc Med; 2022; 9():938540. PubMed ID: 35966557 [TBL] [Abstract][Full Text] [Related]
32. Association of Metabolic Syndrome with Adverse Outcomes in Patients with Stable Coronary Artery Disease: A Meta-Analysis. Su Y; Zhang X Horm Metab Res; 2023 Feb; 55(2):96-102. PubMed ID: 36113500 [TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of MicroRNAs in Coronary Artery Diseases: A Meta-Analysis. Kim JS; Pak K; Goh TS; Jeong DC; Han ME; Kim J; Oh SO; Kim CD; Kim YH Yonsei Med J; 2018 Jun; 59(4):495-500. PubMed ID: 29749132 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of coronary artery disease-reporting and data system (CAD-RADS) score for cardiovascular events in ischemic stroke. Nam K; Hur J; Han K; Im DJ; Suh YJ; Hong YJ; Lee HJ; Kim YJ; Choi BW Atherosclerosis; 2019 Aug; 287():1-7. PubMed ID: 31176800 [TBL] [Abstract][Full Text] [Related]
35. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis. Lin Y; Liu Z; Qiu Y; Zhang J; Wu H; Liang R; Chen G; Qin G; Li Y; Zou D Eur J Surg Oncol; 2018 Oct; 44(10):1494-1503. PubMed ID: 30100361 [TBL] [Abstract][Full Text] [Related]
36. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction. Erkol A; Oduncu V; Turan B; Kılıçgedik A; Sırma D; Gözübüyük G; Karabay CY; Guler A; Dündar C; Tigen K; Pala S; Kırma C J Thromb Thrombolysis; 2014 Oct; 38(3):339-47. PubMed ID: 24407374 [TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis. Bao Q; Zhang J; Wu X; Zhao K; Guo Y; Yang M; Du X Cerebrovasc Dis; 2023; 52(3):318-343. PubMed ID: 36279857 [TBL] [Abstract][Full Text] [Related]
39. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study. Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM; Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425 [TBL] [Abstract][Full Text] [Related]
40. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Koenig W; Rothenbacher D; Hoffmeister A; Griesshammer M; Brenner H Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1701-5. PubMed ID: 11597948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]